SEC Form 4 · accession 0001140361-15-043569
HEALTHEQUITY, INC. · HQY
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Ashley Dreier
Officer — Executive VP, CTO and CIO
Period of report
Dec 1, 2015
Accepted (ET)
Dec 3, 2015 · 4:35 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001428336
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 1, 2015 | M | 3,125 | $1.50 | A | 3,125 | D | |
| Common StockF2 | Dec 1, 2015 | S | 1,725 | $32.0083 | D | 1,400 | D | |
| Common StockF3 | Dec 1, 2015 | S | 1,400 | $32.71 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F4 | $1.50 | Dec 1, 2015 | M | 3,125 | D | — | May 9, 2023 | Common Stock | 3,125 | 87,500 | D |
| Stock Option (right to buy)F5,F6 | $1.50 | holding | — | — | — | — | May 9, 2023 | Common Stock | 100,000 | 100,000 | D |
Explanation of responses
- F1The option exercise and subsequent sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on January 15, 2015.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.51 to $32.50, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) and (3) to this Form 4.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.55 to $32.82, inclusive.
- F4The option becomes exercisable in four equal installments on May 9, 2014, 2015, 2016 and 2017.
- F5As previously reported in the reporting person's Form 3, the option grant had a $2.50 exercise price upon issuance. The $2.50 exercise price was automatically adjusted to $1.50 on August 4, 2014 as a result of the occurrence of an event specified in the terms of the option grant at the time of its issuance.
- F6The option is immediately exercisable.